Patent AT-E401315-T1: [Translated] 5-(2,3-DIALKOXYPHENYL)-4,1-BENZOXAZEPINE-2-ONE AS ANTI-HYPERLIPIDEMIC AGENT

This invention provides new benzoxazepine compounds represented by the formula: Äwherein R stands for a lower alkyl group optionally substituted with a hydroxyl group, X stands for an optionally substituted carbamoyl group or an optionally substituted heterocyclic group having a deprotonatable hydrogen atom, R1 stands for a lower alkyl group and W stands for a halogen atomÜ having activities of lowering chlesterol-level and lowering trigluceride-level, and being useful for prophylaxis and therapy of hyperlipidemia.